Heparin versus bivalirudin anticoagulation management for extracorporeal membrane oxygenation in covid-19: 1-year institutional review
ASAIO Journal
; 67(SUPPL 3):10, 2021.
Article
in English
| EMBASE | ID: covidwho-1481520
ABSTRACT
Introduction:
Anticoagulation strategies for extracorporeal membrane oxygenation(ECMO) support in COVID-19 patients remains controversial. This study aims to present our experience with anticoagulation management and monitoring strategies including bleeding complications during ECMO support.Methods:
Retrospectively, we reviewed charts of twelve patients supported with ECMO for COVID-19 from March 2020 to June 2021. Of these, eight patients with veno-venous(VV) ECMO received intravenous(IV) heparin anticoagulation and four with veno-arterial-venous(VAV) ECMO received IV Bivalirudin. Therapeutic partial thromboplastin time(PTT) goal was 50-70seconds in both groups.Results:
Average age was 52 years with nine males. All patients had elevated D-dimer level before and during ECMO support. Mean time on ECMO support was 800.3 hours. Overall, therapeutic PTT was achieved in 38% with significant outcomes in Bivalirudin when compared to Heparin group [Heparin33%(24-49%);Bivalirudin51%(24-92%), P<0.00001]. Number of patients remained sub-therapeutic (PTT<50s) was 60% [Heparin63%;Bivalirudin48.2%], and supra-therapeutic (PTT>70s) was 2% [Heparin3%;Bivalirudin0.9%]. In heparin group, major bleeding complications included cerebral in 4, oropharyngeal in 2, and psoas hematoma in 2 patients. Whereas, in Bivalirudin group, only one patient experienced postoperative anemia from acute blood loss. Overall, six died in hospital [Heparin5patients;Bivalirudin1patient];two discharged to another hospital for lung transplant [Heparin0patient;Bivalirudin2patients, 1 died before listing];three discharged to home alive [Heparin3patients;Bivalirudin0patient], and one still remains in the hospital [Heparin0patient;Bivalirudin1patient].Conclusion:
Although results are promising for Bivalirudin in terms of lesser hemorrhagic complications and reduced mortality, smaller sample size may have attenuated the findings. Future studies are warranted.
Search on Google
Collection:
Databases of international organizations
Database:
EMBASE
Language:
English
Journal:
ASAIO Journal
Year:
2021
Document Type:
Article
Similar
MEDLINE
...
LILACS
LIS